ClearWorks Particulate Respirator

PROJECT SUMMARY The ClearWorks respirator, developed by Applied Design Technologies, addresses the critical need for comfortable and effective respiratory protection for healthcare workers (HCWs) in the face of infectious diseases, like COVID-19. Current respirators often lack both optimal breathability and a secure seal, causing discomfort and increased exposure risk. ClearWorks aims to revolutionize this field with its foam half mask respirator design. The significance of this project lies in protecting HCWs' health and well-being, especially considering the high mortality rates reported among healthcare workers due to COVID-19. ClearWorks respirators offer a range of advantages, including exceptional breathability, a universal fit across different head sizes, transparency for social acceptance and visual speech recognition, lightweight design, reduced CO2 levels, and minimal facial contact pressure. These features are expected to enhance overall comfort and usability, thereby increasing the likelihood of consistent respirator usage during prolonged shifts, a challenge reported by many HCWs. With its unique modular component architecture, ClearWorks provides opportunities for cost-effective upgrades and customization, while its innovative foam seal design and pleated filters contribute to comfort and breathability. To validate ClearWorks' effectiveness, the prototype will undergo rigorous testing in this Phase I SBIR, including Fit Factor assessments and resistance testing, adhering to NIOSH standards. These tests will demonstrate the product's superior performance in ensuring a secure seal and minimizing breathing resistance. Additionally, third-party validation by a highly regarded testing provider will provide independent confirmation of the research findings. The ClearWorks respirator project aims to address a significant gap in respiratory protection for healthcare workers and essential personnel. By combining innovation in design, materials, and fit, ClearWorks seeks to reshape the landscape of respiratory protection, ultimately improving the safety and well-being of those on the front lines of infectious disease control. The product's commercial potential is substantial, targeting the healthcare sector, home health nurses, and broader essential worker categories.